Brief: Humanigen Announces Peer-Reviewed Publication In Thorax Supporting Early Treatment Of Hospitalized Covid-19 Patients With Lenzilumab Guided By C-Reactive Protein

Humanigen

06/07/2022 13:05

July 6 (Reuters) - Humanigen Inc  HGEN.O :
    * HUMANIGEN ANNOUNCES PEER-REVIEWED PUBLICATION IN THORAX
SUPPORTING EARLY TREATMENT OF HOSPITALIZED COVID-19 PATIENTS
WITH LENZILUMAB GUIDED BY C-REACTIVE PROTEIN
    * HUMANIGEN - PARTICIPANTS IN STUDY WITH BASELINE CRP <150
MG/L
TREATED WITH LENZILUMAB SHOWED 62% REDUCTION IN RELATIVE RISK OF
INVASIVE MECHANICAL VENTILATION, DEATH VERSUS PLACEBO

Source text for Eikon:  ID:nBw8zd3CXa 
Further company coverage:  HGEN.O